These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17239819)

  • 1. Identification of novel short peptides derived from the alpha 4, alpha 5, and alpha 6 fibrils of type IV collagen with anti-angiogenic properties.
    Karagiannis ED; Popel AS
    Biochem Biophys Res Commun; 2007 Mar; 354(2):434-9. PubMed ID: 17239819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cells.
    Karagiannis ED; Popel AS
    Int J Biochem Cell Biol; 2007; 39(12):2314-23. PubMed ID: 17707681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis.
    Maeshima Y; Yerramalla UL; Dhanabal M; Holthaus KA; Barbashov S; Kharbanda S; Reimer C; Manfredi M; Dickerson WM; Kalluri R
    J Biol Chem; 2001 Aug; 276(34):31959-68. PubMed ID: 11399763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model.
    Koskimaki JE; Karagiannis ED; Tang BC; Hammers H; Watkins DN; Pili R; Popel AS
    BMC Cancer; 2010 Feb; 10():29. PubMed ID: 20122172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the functions of endogenous angiogenesis inhibitors.
    Grant MA; Kalluri R
    Cold Spring Harb Symp Quant Biol; 2005; 70():399-410. PubMed ID: 16869777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chapter 1. Molecular mechanism of type IV collagen-derived endogenous inhibitors of angiogenesis.
    Cooke VG; Kalluri R
    Methods Enzymol; 2008; 444():1-19. PubMed ID: 19007658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and development of anti-angiogenic peptides: A structural link.
    Dings RP; Nesmelova I; Griffioen AW; Mayo KH
    Angiogenesis; 2003; 6(2):83-91. PubMed ID: 14739615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
    Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
    J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
    Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of neostatins, the MMP-derived, enzymatic cleavage products of type XVIII collagen.
    Chang JH; Javier JA; Chang GY; Oliveira HB; Azar DT
    FEBS Lett; 2005 Jul; 579(17):3601-6. PubMed ID: 15978592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer.
    Rosca EV; Koskimaki JE; Pandey NB; Wolff AC; Popel AS
    Cancer Biol Ther; 2011 Nov; 12(9):808-17. PubMed ID: 21878750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV.
    Weckmann M; Moir LM; Heckman CA; Black JL; Oliver BG; Burgess JK
    J Cell Mol Med; 2012 Dec; 16(12):3062-73. PubMed ID: 22998238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic activity of the mutant Dutch A(beta) peptide on human brain microvascular endothelial cells.
    Paris D; Ait-Ghezala G; Mathura VS; Patel N; Quadros A; Laporte V; Mullan M
    Brain Res Mol Brain Res; 2005 May; 136(1-2):212-30. PubMed ID: 15893605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
    Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The anti-angiogenesis effect of plasminogen kringle 5].
    Cai WB; Liu QP; Gao GQ
    Sheng Li Ke Xue Jin Zhan; 2004 Apr; 35(2):159-62. PubMed ID: 15285426
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer.
    Rosca EV; Penet MF; Mori N; Koskimaki JE; Lee E; Pandey NB; Bhujwalla ZM; Popel AS
    PLoS One; 2014; 9(11):e111901. PubMed ID: 25384034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
    He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
    Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPARC is a source of copper-binding peptides that stimulate angiogenesis.
    Lane TF; Iruela-Arispe ML; Johnson RS; Sage EH
    J Cell Biol; 1994 May; 125(4):929-43. PubMed ID: 7514608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel peptide-specific quantitative structure-activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity.
    Rivera CG; Rosca EV; Pandey NB; Koskimaki JE; Bader JS; Popel AS
    J Med Chem; 2011 Oct; 54(19):6492-500. PubMed ID: 21866962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.